Induction of Labor at Term for Severe Antenatal Lead Poisoning

J Med Toxicol. 2023 Oct;19(4):401-404. doi: 10.1007/s13181-023-00955-1. Epub 2023 Jun 26.

Abstract

Introduction: Antenatal lead exposure is associated with multiple adverse maternal and fetal consequences. Maternal blood lead concentrations as low as 10 µg/dL have been associated with gestational hypertension, spontaneous abortion, growth retardation, and impaired neurobehavioral development. Current treatment recommendations for pregnant women with a blood lead level (BLL) ≥ 45 µg/dL include chelation. We report a successful case of a mother with severe gestational lead poisoning treated with induction of labor in a term infant.

Case report: A 22-year-old G2P1001 female, at 38 weeks and 5 days gestation, was referred to the emergency department for an outpatient venous BLL of 53 µg/dL. The decision was made to limit ongoing prenatal lead exposure by emergent induction as opposed to chelation. Maternal BLL just prior to induction increased to 70 µg/dL. A 3510 g infant was delivered with APGAR scores of 9 and 9 at 1 and 5 min. Cord BLL at delivery returned at 41 µg/dL. The mother was instructed to avoid breastfeeding until her BLLs decreased to below 40 µg/dL, consistent with federal and local guidelines. The neonate was empirically chelated with dimercaptosuccinic acid. On postpartum day 2, maternal BLL decreased to 36 µg/dL, and the neonatal BLL was found to be 33 µg/mL. Both the mother and neonate were discharged to an alternative lead-free household on postpartum day 4.

Keywords: CaNa2EDTA; Chelation; DMSA; Lead; Neonate; Pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Chelating Agents / therapeutic use
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Labor, Induced
  • Lead Poisoning* / diagnosis
  • Lead Poisoning* / drug therapy
  • Lead Poisoning* / etiology
  • Lead*
  • Pregnancy
  • Succimer / therapeutic use
  • Young Adult

Substances

  • Lead
  • Chelating Agents
  • Succimer